Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1987 | 1 |
1997 | 1 |
1999 | 1 |
2000 | 2 |
2001 | 1 |
2003 | 4 |
2004 | 4 |
2005 | 3 |
2006 | 6 |
2007 | 8 |
2008 | 12 |
2009 | 7 |
2010 | 12 |
2011 | 6 |
2012 | 6 |
2013 | 14 |
2014 | 20 |
2015 | 19 |
2016 | 32 |
2017 | 24 |
2018 | 22 |
2019 | 24 |
2020 | 21 |
2021 | 22 |
2022 | 31 |
2023 | 19 |
2024 | 8 |
Search Results
288 results
Results by year
Day 15 HDRS-17 least-squares mean (LSM) CFB was -12.5 (zuranolone 30 mg) vs -11.1 (placebo; P = .116). Improvement vs placebo was significant at days 3, 8, and 12 (all P < .05). ...Post hoc analyses of zuranolone 30 mg in patients with measurable plasma zuranolon
…Twenty-five of 31 patients had tumor mutation profiling: 8 of 9 (89%) patients with a TSC2 mutation achieved a confirmed response versus 2 of 16 (13%) without TSC2 mutation (P < .001). The median progression-free survival was 10.6 months (95% CI, 5.5 months to not reach
…